Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide core.
暂无分享,去创建一个
C. Fotsch | Markian M Stec | N. Xi | Shimin Xu | C. Hale | J. Baumgartner | M. Kelly | M. H. Norman
[1] Michael G Kelly,et al. Design of a new peptidomimetic agonist for the melanocortin receptors based on the solution structure of the peptide ligand, Ac-Nle-cyclo[Asp-Pro-DPhe-Arg-Trp-Lys]-NH(2). , 2003, Bioorganic & medicinal chemistry letters.
[2] D. Johnston,et al. Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. , 2002, Journal of medicinal chemistry.
[3] T. Ando,et al. 2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor. , 2002, Journal of medicinal chemistry.
[4] A. Turnbull,et al. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. , 2002, The Journal of endocrinology.
[5] Terry Kenakin,et al. Efficacy at g-protein-coupled receptors , 2002, Nature Reviews Drug Discovery.
[6] J Lindblom,et al. New aspects on the melanocortins and their receptors. , 2000, Pharmacological research.
[7] J. Metzger,et al. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice , 2000, Transgenic Research.
[8] J. Wikberg,et al. Melanocortin receptors: perspectives for novel drugs. , 1999, European journal of pharmacology.
[9] V. Hruby,et al. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. , 1998, The Journal of urology.
[10] H. Broughton,et al. Serine derived NK1 antagonists. 2: A pharmacophore model for arylsulfonamide binding. , 1998, Bioorganic & medicinal chemistry letters.
[11] Victor J. Hruby,et al. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.
[12] V. Hruby,et al. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. , 1989, Journal of medicinal chemistry.
[13] V. Hruby,et al. Amino acid mimetics and design of peptidomimetics for opioid and melanocortin receptors: General perspectives , 1999 .
[14] Davidr . Evans,et al. 1 – Stereoselective Alkylation Reactions of Chiral Metal Enolates , 1984 .